Form 4 holding
10%+ Owner
Sana Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 11,441,326
- Estimated value
- $45,780,178
- Report date
- 06 Jun 2023
- Price
- $4.00
- Ownership
- By Flagship VentureLabs V, LLC
Flagship Ventures Fund V General Partner LLC
Insider Reports History
- Location
- Cambridge, MA
- SEC signature
- Flagship Ventures Fund V General Partner LLC, By: /s/ Noubar B. Afeyan Ph.D., Title: Manager
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
1 fact
SEC filing record
1 fact
SEC evidence
1 fact
Holdings reported by Flagship Ventures Fund V General Partner LLC:
Form 4 holding
10%+ Owner
Sana Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 10,743,293
- Estimated value
- $42,987,138
- Report date
- 07 Jun 2023
- Price
- $4.00
- Ownership
- By Flagship Ventures Fund V, L.P.
Form 4 holding
10%+ Owner
Sana Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 9,725,122
- Estimated value
- $38,913,131
- Report date
- 06 Jun 2023
- Price
- $4.00
- Ownership
- By Flagship Pioneering Fund VI, L.P.
Form 4 holding
10%+ Owner
Sana Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 1,380,277
- Estimated value
- $5,522,902
- Report date
- 07 Jun 2023
- Price
- $4.00
- Ownership
- By Flagship V VentureLabs Rx Fund, L.P.
Form 4 holding
10%+ Owner
Codiak BioSciences, Inc.
- Security class
- Common Stock
- Shares / value
- 1,865,767
- Estimated value
- Report date
- 15 Sep 2022
- Price
- Ownership
- By Flagship Ventures Fund V, L.P.
Form 4 holding
10%+ Owner
Codiak BioSciences, Inc.
- Security class
- Common Stock
- Shares / value
- 1,188,920
- Estimated value
- Report date
- 15 Sep 2022
- Price
- Ownership
- By Flagship V VentureLabs Rx Fund, L.P.
Form 4 holding
10%+ Owner
Codiak BioSciences, Inc.
- Security class
- Warrants to purchase Common Stock
- Shares / value
- 722,590
- Estimated value
- Report date
- 15 Sep 2022
- Price
- Ownership
- By Flagship Ventures Fund V, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Codiak BioSciences, Inc.
- Security class
- Common Stock
- Shares / value
- 485,949
- Estimated value
- Report date
- 15 Sep 2022
- Price
- Ownership
- Flagship VentureLabs V LLC
Form 4 holding
10%+ Owner
Codiak BioSciences, Inc.
- Security class
- Warrants to purchase Common Stock
- Shares / value
- 210,743
- Estimated value
- Report date
- 15 Sep 2022
- Price
- Ownership
- By Flagship V VentureLabs Rx Fund, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Sigilon Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 11 Aug 2023
- Price
- Ownership
- By Flagship Pioneering Special Opportunities Fund II, L.P.
Form 4 holding
10%+ Owner
Sigilon Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 11 Aug 2023
- Price
- Ownership
- By Flagship Ventures Fund V, L.P.
Insider Reports Filed by Flagship Ventures Fund V General Partner LLC
4
Sigilon Therapeutics, Inc.
- Report period
- 11 Aug 2023
- Transactions
- 2
- Transaction value
- -$11,901,982
- Filing time
- 15 Aug 2023, 16:15
- Role
- 10%+ Owner
- Next action
- Open filing details
4
SANA
Sana Biotechnology, Inc.
- Report period
- 06 Jun 2023
- Transactions
- 4
- Transaction value
- -$2,532,858
- Filing time
- 08 Jun 2023, 19:00
- Role
- 10%+ Owner
- Next action
- Open filing details
4
SANA
Sana Biotechnology, Inc.
- Report period
- 24 May 2023
- Transactions
- 6
- Transaction value
- -$3,527,275
- Filing time
- 26 May 2023, 20:00
- Role
- 10%+ Owner
- Next action
- Open filing details
4
Codiak BioSciences, Inc.
- Report period
- 15 Sep 2022
- Transactions
- 4
- Transaction value
- $0
- Filing time
- 16 Sep 2022, 19:30
- Role
- 10%+ Owner
- Next action
- Open filing details